Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer
Titel:
Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer
Auteur:
Pérol, Maurice Pavlakis, Nick Levchenko, Evgeny Platania, Marco Oliveira, Julio Novello, Silvia Chiari, Rita Moran, Teresa Mitry, Emmanuel Nüesch, Eveline Liu, Ting Balas, Bogdana Konopa, Krzysztof Peters, Solange